Identification of novel inhibitors to prevent microbial production of pro diabet...
Identification of novel inhibitors to prevent microbial production of pro diabetic metabolites
The gut microbiota has been associated with metabolic diseases, such as type 2 diabetes. In my ERC consolidator award we demonstrated that the gut microbiota is altered following bariatric surgery and that the altered microbiota m...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Healthybiota
Microbiota host interactions for integrative metabolic healt...
2M€
Cerrado
IMPACT
Imidazole propionate and fibrosis in cardiometabolic disease...
2M€
Cerrado
IRBETAINE-CIG
Molecular mechanisms underlying the development of insulin r...
100K€
Cerrado
ENIGMO
Gut microbiota innate immunity and endocannabinoid system i...
1M€
Cerrado
PID2019-110063RA-I00
EFICACIA DE UNA ESTRATEGIA DE EDUCACION NUTRICIONAL Y EL ROL...
36K€
Cerrado
Información proyecto Drug the bug
Duración del proyecto: 18 meses
Fecha Inicio: 2017-11-22
Fecha Fin: 2019-05-31
Líder del proyecto
GOETEBORGS UNIVERSITET
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
150K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The gut microbiota has been associated with metabolic diseases, such as type 2 diabetes. In my ERC consolidator award we demonstrated that the gut microbiota is altered following bariatric surgery and that the altered microbiota may be directly linked to some of the metabolic improvements observed following surgery. Interestingly, improved metabolism was associated with altered metabolite production capacity from the microbiota and we observed that a metabolite, imidazole propionate, was reduced after surgery. In associated projects we have demonstrated that imidazole propionate is associated with type 2 diabetes in humans and induce insulin resistance in primary hepatocytes and when injected into mice. Imidazole propionate is synthesized by the microbial enzyme UrdA from histidine. This POC will explore the potential of identifying inhibitors of UrdA to reduce production of imidazole propionate and thereby improve insulin sensitivity. If successful we envision a new class of diabetes medication based on the concept of drug the bug.